Dove launches new bone densitometer
Dove Medical Systems has introduced a new bone densitometer inits OsteoAnalyzer line that is designed to provide low-cost bonemineral density exams. The system, SXA 3000, sells for under $20,000and measures bone density in the heel at the push of a
Dove Medical Systems has introduced a new bone densitometer inits OsteoAnalyzer line that is designed to provide low-cost bonemineral density exams. The system, SXA 3000, sells for under $20,000and measures bone density in the heel at the push of a singlebutton, according to the Newbury Park, CA, company.
Earlier this year, Dove signed a deal with Merck in which thatpharmaceutical firm will provide equipment financing support forphysicians purchasing Dove bone densitometers. Merck, which ismarketing its Fosamax drug for the treatment of osteoporosis,has signed similar deals with a number of other bone densitometryvendors (SCAN 2/14/96 and 7/6/95).
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
